BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nezos A, Evangelopoulos ME, Mavragani CP. Genetic contributors and soluble mediators in prediction of autoimmune comorbidity. J Autoimmun 2019;104:102317. [PMID: 31444033 DOI: 10.1016/j.jaut.2019.102317] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Argyriou E, Nezos A, Roussos P, Venetsanopoulou A, Voulgarelis M, Boki K, Tzioufas AG, Moutsopoulos HM, Mavragani CP. Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3): A Novel Marker for Lymphoma Development among Patients with Young Onset Sjogren's Syndrome. J Clin Med 2021;10:644. [PMID: 33567548 DOI: 10.3390/jcm10040644] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Nezos A, Skarlis C, Psarrou A, Markakis K, Garantziotis P, Papanikolaou A, Gravani F, Voulgarelis M, Tzioufas AG, Koutsilieris M, Moutsopoulos HM, Kotsifaki E, Mavragani CP. Lipoprotein-Associated Phospholipase A2: A Novel Contributor in Sjögren's Syndrome-Related Lymphoma? Front Immunol 2021;12:683623. [PMID: 34220834 DOI: 10.3389/fimmu.2021.683623] [Reference Citation Analysis]
3 Skarlis C, Raftopoulou S, Mavragani CP. Sjogren's Syndrome: Recent Updates. J Clin Med 2022;11:399. [PMID: 35054094 DOI: 10.3390/jcm11020399] [Reference Citation Analysis]
4 Lin CY, Chen HA, Wu CH, Su YJ, Hsu TC, Hsu CY. Is Behçet's syndrome associated with an increased risk of ischemic heart disease? A real-world evidence in Taiwan. Arthritis Res Ther 2021;23:161. [PMID: 34088352 DOI: 10.1186/s13075-021-02543-6] [Reference Citation Analysis]
5 Wang Y, Xiao S, Xia Y, Wang H. The Therapeutic Strategies for SLE by Targeting Anti-dsDNA Antibodies. Clin Rev Allergy Immunol 2021. [PMID: 34542806 DOI: 10.1007/s12016-021-08898-7] [Reference Citation Analysis]
6 Yu H, Liu H, Zhao Y, Wang H, Liu C, Qi W, Liu Z, Sun Y, Gao S, Tao J, Fu R, Shao Z. Upregulated expression of leukocyte immunoglobulin-like receptor A3 in patients with severe aplastic anemia. Exp Ther Med 2021;21:346. [PMID: 33732319 DOI: 10.3892/etm.2021.9777] [Reference Citation Analysis]
7 Cinoku II, Verrou KM, Piperi E, Voulgarelis M, Moutsopoulos HM, Mavragani CP. Interferon (IFN)-stimulated gene 15: A novel biomarker for lymphoma development in Sjögren's syndrome. J Autoimmun 2021;123:102704. [PMID: 34298409 DOI: 10.1016/j.jaut.2021.102704] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Chen DY, Sawamura T, Dixon RAF, Sánchez-Quesada JL, Chen CH. Autoimmune Rheumatic Diseases: An Update on the Role of Atherogenic Electronegative LDL and Potential Therapeutic Strategies. J Clin Med 2021;10:1992. [PMID: 34066436 DOI: 10.3390/jcm10091992] [Reference Citation Analysis]